Hepatic Targeting Gene Delivery Using Galactosylated Ester-Based Polyspermine

You-Kyoung Kim,Mei Zhang,Bing-Feng Zhang,Feng-Zhen Wang,Peng-Fei Cui,Rong-Lin Xie,Lei Xing,Hu-Lin Jiang
DOI: https://doi.org/10.1166/jnn.2016.11341
2016-01-01
Journal of Nanoscience and Nanotechnology
Abstract:The clinical application of spermine (SPE) as a biocompatible non-viral gene vector was hindered by its poor capacity to condense nucleic acid. We have previously crosslinked SPE with glycerol propoxylate triacrylate (GPT) for a biodegradable gene vector, glycerol propoxylate triacrylated spermine (GPT-SPE), but it still lacked good cell specificity to deliver gene to target site. To resolve this obstacle, galactose (Gal) was introduced into GPT-SPE via an acylation reaction to build a biodegradable and hepatic targeting gene vector, galactosylated glycerol propoxylate triacrylated spermine (Gal-GPT-SPE). Gal-GPT-SPE showed low cytotoxicity in HepG2 and A549 cell lines. At functional weight ratios, the transfection efficiency of Gal-GPT-SPE was higher than that of GPT-SPE and PEI 25K in HepG2 cell line. In vivo delivery of Pdcd4, a therapeutic gene, with Gal-GPT-SPE significantly inhibited hepatic carcinoma in H-ras12V transgenic mice. Gal-GPT-SPE showed remarkably enhanced specificity towards hepatocytes both in vivo and in vitro as a result of the interaction between Gal and asialoglycoprotein receptor. Altogether, it was reasonable to assume that Gal-GPT-SPE was a novel biodegradable, hepatic targeting gene vector. With further investigation and development, Gal-GPT-SPE can be developed as an effective and safe targeting gene vehicle for hepatic carcinoma.
What problem does this paper attempt to address?